Hepp U, Kraemer B, Schnyder U, Miller N, Delsignore A
Department of Psychiatry, University Hospital, Culmannstrasse 8, Zurich CH-8091, Switzerland.
J Psychosom Res. 2005 Mar;58(3):259-61. doi: 10.1016/j.jpsychores.2004.08.010.
Despite being recognized as an important prognostic factor for the outcome in gender identity disorder (GID), psychiatric comorbidity has rarely been assessed by means of standardized diagnostic instruments. The aim of this study was to assess current and lifetime psychiatric comorbidity in patients with GID.
A cross-sectional sample of 31 patients who were treated for GID was assessed by the structured clinical interview for Axis I and II (SCID-I/II) and the Hospital Anxiety and Depression Scale (HADS).
Twenty-nine percent of the patients had no current or lifetime Axis I disorder; 39% fulfilled the criteria for current and 71% for current and/or lifetime Axis I diagnosis. Forty-two percent of the patients were diagnosed with one or more personality disorders.
Lifetime psychiatric comorbidity in GID patients is high, and this should be taken into account in the assessment and treatment planning of GID patients.
尽管精神共病被认为是性别认同障碍（GID）预后的一个重要因素，但很少通过标准化诊断工具对其进行评估。本研究的目的是评估GID患者当前及终生的精神共病情况。
采用针对轴I和轴II的结构化临床访谈（SCID-I/II）以及医院焦虑抑郁量表（HADS），对31例接受GID治疗的患者进行横断面抽样评估。
29%的患者当前或终生均无轴I障碍；39%符合当前轴I诊断标准，71%符合当前和/或终生轴I诊断标准。42%的患者被诊断患有一种或多种人格障碍。
GID患者终生精神共病率较高，在GID患者的评估和治疗规划中应考虑这一点。
